Therefore, we speculated that the deletion of LOX-1 under DOX treatment results in a significant reversal of DOX-induced cardiac fibrosis in our experiment, which could attenuate DOX-induced cardiomyopathy. Here, OLR1 is linked to cardiomyopathy.